Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Stability of neurological signs with clozapine treatment.

Literature DB >> 7948457

Stability of neurological signs with clozapine treatment.

R W Buchanan¹, P Koeppl, A Breier.

Abstract

Entities: Chemical

Mesh：

Substances：
Clozapine
Haloperidol

Year: 1994 PMID： 7948457 DOI： 10.1016/0006-3223(94)91225-4

Source DB: PubMed Journal: Biol Psychiatry ISSN： 0006-3223 Impact factor: 13.382

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Predictors and markers of clozapine response.

Authors: Carmen Chung; Gary Remington
Journal: Psychopharmacology (Berl) Date: 2005-02-17 Impact factor: 4.530

2. Evaluating the use of the wilbarger intervention with schizophrenic patients: a pilot study.

Authors: David J Withersty; Janet Stout; Neil L Mogge; Anita Nesland; G David Allen
Journal: Psychiatry (Edgmont) Date: 2005-01

3. Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia.

Authors: Konstantinos N Fountoulakis; Panagiotis Panagiotidis; Thomas Tegos; Vasileios Kimiskidis; Ioannis Nimatoudis
Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-11-29 Impact factor: 5.760

4. Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

Authors: S Kristian Hill; John A Sweeney; Robert M Hamer; Richard S E Keefe; Diana O Perkins; Hongbin Gu; Joseph P McEvoy; Jeffrey A Lieberman
Journal: J Int Neuropsychol Soc Date: 2008-03 Impact factor: 2.892

Stability of neurological signs with clozapine treatment.

Review 1. Predictors and markers of clozapine response.

2. Evaluating the use of the wilbarger intervention with schizophrenic patients: a pilot study.

3. Paternal age and specific neurological soft signs as reliable and valid neurobiological markers for the diagnosis of patients with schizophrenia.

4. Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia.

5. Cognitive neurosciences: A new paradigm in management and outcome of schizophrenia.

6. Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers.

7. Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia.

Review 8. Clozapine versus typical neuroleptic medication for schizophrenia.

Review 9. Neurological soft signs in the clinical course of schizophrenia: results of a meta-analysis.

10. Neurological soft signs in individuals with pathological gambling.